Target intelligence / Profile preview

TPRG1 antisense RNA 2 (non-protein coding) (TPRG1-AS2)

Target
TPRG1-AS2
Molecular classification
Long noncoding RNA (lncRNA), Natural antisense transcript
01

Overview

TPRG1 antisense RNA 2 (TPRG1-AS2) is a long noncoding RNA gene located on human chromosome 3, transcribed from the strand opposite the TPRG1 locus. As an antisense RNA, it does not encode a protein but may play a regulatory role at the RNA level, influencing gene expression through mechanisms common among natural antisense transcripts, such as transcriptional interference, mRNA stabilization/destabilization, or modulation of transcription factor binding. At present, specific biological or clinical functions of TPRG1-AS2 have not been experimentally characterized or published. The molecule is structurally similar in nomenclature to TPRG1-AS1, which has demonstrated biological effects in vascular biology (notably suppressing smooth muscle cell migration and neointima formation), but direct evidence for TPRG1-AS2 is currently lacking. While the related TPRG1-AS1 has characterized roles, there is no credible evidence that TPRG1-AS2 itself is a drug target against which a therapeutic intervention (e.g., small molecule, antibody, antisense oligonucleotide) is currently being developed. Thus, it is classified as a long noncoding RNA with unknown or uncharacterized biological function. It is not considered a therapeutic target as of this time.

Other names
TPRG1 antisense RNA 2TPRG1-AS2TPRG1 antisense RNA 2 (non-protein coding)
02

Biological functions

Regulation of gene expression (epigenetic/transcriptional/post-transcriptional mechanisms typical for lncRNAs and antisense RNAs)Possible involvement in modulating cellular behavior, although specific effects for TPRG1-AS2 are uncharacterized in the available literature
03

Disease associations

Other (no direct evidence published for TPRG1-AS2 in a specific disease context was found, but related antisense lncRNAs can modulate cancer, cardiovascular, or inflammatory diseases)TPRG1-AS1 (closely related, but not identical) is implicated in atherosclerosis and possibly as a diagnostic biomarker for coronary artery disease

Beyond the preview

Go deeper on TPRG1 antisense RNA 2 (non-protein coding) (TPRG1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPRG1 antisense RNA 2 (non-protein coding) (TPRG1-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call